0001209191-22-030044.txt : 20220518
0001209191-22-030044.hdr.sgml : 20220518
20220518162803
ACCESSION NUMBER: 0001209191-22-030044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Garabedian Christopher Nishan
CENTRAL INDEX KEY: 0001843665
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39971
FILM NUMBER: 22939495
MAIL ADDRESS:
STREET 1: C/O LANDOS BIOPHARMA, INC.
STREET 2: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Landos Biopharma, Inc.
CENTRAL INDEX KEY: 0001785345
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815085535
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
BUSINESS PHONE: 540-818-2844
MAIL ADDRESS:
STREET 1: 1800 KRAFT DRIVE, SUITE 216
CITY: BLACKSBURG
STATE: VA
ZIP: 24060
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-16
0
0001785345
Landos Biopharma, Inc.
LABP
0001843665
Garabedian Christopher Nishan
C/O LANDOS BIOPHARMA, INC.
1800 KRAFT DRIVE, SUITE 216
BLACKSBURG
VA
24060
1
0
0
0
Stock Option (right to buy)
0.6434
2022-05-16
4
A
0
18000
0.00
A
2032-05-15
Common Stock
18000
18000
D
1/12th of the shares subject to this option will vest and become exercisable in equal monthly installments commencing May 19, 2022, subject to the Reporting Person providing continuous service to the Issuer.
/s/ Eric W. Blanchard, Attorney-in-Fact
2022-05-18